Gladstone Institutional Advisory’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,075
Closed -$205K 704
2021
Q4
$205K Sell
8,075
-200
-2% -$5.16K 0.02% 561
2021
Q3
$223K Buy
+8,275
New +$237K 0.02% 495

Other funds holding BMEZ

Gladstone Institutional Advisory's BMEZ Position: Q1 2022 in Review

Gladstone Institutional Advisory sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2022, closing a stake of 8,075 shares — an estimated $205K sold.

Gladstone Institutional Advisory first reported a position in BMEZ in Q3 2021 and held it in 2 quarters. The position peaked at $223K in Q3 2021. 69 funds tracked by Wall St. Rank hold BMEZ as of Q1 2022.

  • Gladstone Institutional Advisory reported no remaining BlackRock Health Sciences Trust II position as of Q1 2022 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 8,075 BlackRock Health Sciences Trust II shares in Q1 2022, an estimated $205K.
  • Gladstone Institutional Advisory first reported a position in BlackRock Health Sciences Trust II in Q3 2021 and held it in 2 quarters.
  • Gladstone Institutional Advisory's BlackRock Health Sciences Trust II position peaked at $223K in Q3 2021.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2022.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2022, filed 4 May 2022.